Agenus

Read more
Garo H. Armen's photo - Chairman & CEO of Agenus

Chairman & CEO

Garo H. Armen

CEO Approval Rating

81/100

Founded:

1994

Status:

PublicIndependent CompanyNASDAQAGEN

AGENUS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Kite Pharma is perceived as one of Agenus's biggest rivals. Kite Pharma was founded in 2009 in Santa Monica, California. Kite Pharma is in the Biotechnology field. Kite Pharma generates $39.8M less revenue than Agenus.

Inovio is Agenus's #2 rival. Inovio is a Public company that was founded in 1979 in Plymouth Meeting, Pennsylvania. Inovio competes in the Pharmaceuticals industry. Compared to Agenus, Inovio has 32 fewer employees.

Immune Design is one of Agenus's top competitors. Immune Design's headquarters is in Seattle, Washington, and was founded in 2008. Like Agenus, Immune Design also operates in the Biotechnology industry. Immune Design generates 2.59% of Agenus's revenue.

Agenus Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$84.8M

Agenus's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 4.6B. Over the last four quarters, Agenus's revenue has decreased by 56.5%. Specifically, in Q1 2021's revenue was $11.7M; in Q4 2020, it was $31.3M; in Q3 2020, it was $14.8M; in Q2 2020, Agenus's revenue was $26.9M.

Agenus Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
PhosImmune, Inc.

Dec 2015

Source »
$9.9M
PhosImmune develops therapeutic cancer vaccines.
4-Antibody AG

Jan 2014

Source »
$50M
-

-

-

Aug 2004

Source »
$undefined
-

Agenus Funding History

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt - PPP (CARES Act)
May 2020
$2M - $5M
Post-IPO Equity
Jan 2019
$30M
-
Post-IPO Equity
Oct 2018
$40M
-
Post-IPO Equity
Feb 2017
$60M
-
Post-IPO Equity
Dec 2015
$500K
-

Agenus Investments

No recent investments found related to Agenus

Agenus News

Agenus Press Releases

Agenus Videos

Social Media

Agenus Headquarters

3 Forbes Road

Lexington, Massachusetts02421-7305

781-674-4400

Driving Directions »

Trending Companies

Agenus Summary

ABOUT

Overview

Agenus is a biotechnology company that researches and develops novel antibodies and vaccines for the treatment of cancer. Agenus was founded in 1994. Agenus' headquarters is located in Lexington, Massachusetts, USA 02421-7305. It has raised 352.2M in ...

CEO

Agenus's Chairman & CEO, Garo H. Armen, currently has an approval rating of 81%. Agenus's primary competitors are Kite Pharma, Inovio & Immune Design.

Frequently Asked Questions about Agenus

  1. When was Agenus founded?

    Agenus was founded in 1994
  2. Who is Agenus's CEO?

    Agenus's CEO is Garo H. Armen
  3. How much revenue does Agenus generate?

    Agenus generates $84.8M in revenue
  4. How much funding does Agenus have?

    Agenus has historically raised $352.2M in funding
  1. Where is Agenus's headquarters?

    Agenus's headquarters is in Lexington Massachusetts, USA
  2. How many employees does Agenus have?

    Agenus has 294 employees
  3. What sector does Agenus operate in?

    Agenus is in Biotechnology
  4. Who are Agenus's competitors?

    Agenus's top competitors are Kite Pharma, Inovio, Immune Design